These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38953039)

  • 21. Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies.
    Courtwright AM; Cao S; Wood I; Mallidi HR; Kawasawa J; Moniodis A; Ng J; El-Chemaly S; Goldberg HJ
    Ann Am Thorac Soc; 2019 Sep; 16(9):1131-1137. PubMed ID: 31026404
    [No Abstract]   [Full Text] [Related]  

  • 22. Pre-transplant impedance measures of reflux are associated with early allograft injury after lung transplantation.
    Lo WK; Burakoff R; Goldberg HJ; Feldman N; Chan WW
    J Heart Lung Transplant; 2015 Jan; 34(1):26-35. PubMed ID: 25444368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension.
    Eberlein M; Diehl E; Bolukbas S; Merlo CA; Reed RM
    J Heart Lung Transplant; 2013 Dec; 32(12):1172-8. PubMed ID: 23876630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.
    Sims MW; Beers MF; Ahya VN; Kawut SM; Sims KD; Lederer DJ; Palmer SM; Wille K; Lama VN; Shah PD; Orens JB; Bhorade S; Crespo M; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
    Chest; 2011 Aug; 140(2):489-496. PubMed ID: 21349925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matching donor to recipient in lung transplantation: How much does size matter?
    Mason DP; Batizy LH; Wu J; Nowicki ER; Murthy SC; McNeill AM; Budev MM; Mehta AC; Pettersson GB; Blackstone EH
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1234-40.e1. PubMed ID: 19379997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Montelukast in chronic lung allograft dysfunction after lung transplantation.
    Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
    J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired recipient pulmonary function is better than lost donor pulmonary function in living-donor lobar lung transplantation.
    Kayawake H; Chen-Yoshikawa TF; Hamaji M; Nakajima D; Ohsumi A; Aoyama A; Date H
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1710-1716.e2. PubMed ID: 31399240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death.
    Keller M; Yang S; Ponor L; Bon A; Cochrane A; Philogene M; Bush E; Shah P; Mathew J; Brown AW; Kong H; Charya A; Luikart H; Nathan SD; Khush KK; Jang M; Agbor-Enoh S
    Am J Transplant; 2023 Apr; 23(4):559-564. PubMed ID: 36732088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
    Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
    Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury.
    Lo WK; Burakoff R; Goldberg HJ; Feldman N; Chan WW
    World J Gastroenterol; 2015 Aug; 21(30):9111-7. PubMed ID: 26290637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early posttransplant reductions in club cell secretory protein associate with future risk for chronic allograft dysfunction in lung recipients: results from a multicenter study.
    Todd JL; Weber JM; Kelly FL; Neely ML; Nagler A; Carmack D; Frankel CW; Brass DM; Belperio JA; Budev MM; Hartwig MG; Martinu T; Reynolds JM; Shah PD; Singer LG; Snyder LD; Weigt SS; Palmer SM
    J Heart Lung Transplant; 2023 Jun; 42(6):741-749. PubMed ID: 36941179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care.
    Keller M; Sun J; Mutebi C; Shah P; Levine D; Aryal S; Iacono A; Timofte I; Mathew J; Varghese A; Giner C; Agbor-Enoh S
    J Heart Lung Transplant; 2022 Apr; 41(4):458-466. PubMed ID: 35063338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donation after circulatory death in lung transplantation-five-year follow-up from ISHLT Registry.
    Van Raemdonck D; Keshavjee S; Levvey B; Cherikh WS; Snell G; Erasmus M; Simon A; Glanville AR; Clark S; D'Ovidio F; Catarino P; McCurry K; Hertz MI; Venkateswaran R; Hopkins P; Inci I; Walia R; Kreisel D; Mascaro J; Dilling DF; Camp P; Mason D; Musk M; Burch M; Fisher A; Yusen RD; Stehlik J; Cypel M;
    J Heart Lung Transplant; 2019 Dec; 38(12):1235-1245. PubMed ID: 31777330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant.
    Husain SA; King KL; Sanichar N; Crew RJ; Schold JD; Mohan S
    JAMA Netw Open; 2021 Apr; 4(4):e215718. PubMed ID: 33847748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
    Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
    J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients.
    Ramendra R; Fernández-Castillo JC; Huszti E; Ghany R; Aversa M; Havlin J; Riddell P; Chaparro CM; Singer LG; Liu L; Keshavjee S; Yeung JC; Martinu T
    ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37817870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.